You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 29, 2025

Profile for Argentina Patent: 077464


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 077464

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jul 6, 2030 Janssen Pharms INVOKAMET canagliflozin; metformin hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Patent AR077464: Scope, Claims, and Landscape

Last updated: August 2, 2025


Introduction

Patent AR077464 represents a significant intellectual property asset within Argentina's pharmaceutical patent landscape. Its strategic importance hinges on the scope of its claims, the specifics of its inventive concept, and its position relative to existing patents. This detailed analysis aims to delineate the patent's scope, interpret its claims, and contextualize its presence within Argentina's pharmaceutical patent environment, supporting strategic decision-making for stakeholders.


Patent Overview and Filing Details

Patent AR077464 was filed on [insert filing date] by [applicant name]. It pertains to a novel pharmaceutical compound/formulation/method (specify as per patent document). The patent was granted on [grant date] and is currently enforceable in Argentina, with a patent term generally extending 20 years from the filing date (subject to maintenance fees and procedural factors).

Relevant legislation: Patent protection is governed by the Argentine Patent Law (Law No. 24,481), which aligns broadly with international standards via TRIPS compliance [1].


Scope of the Patent: Claims

The scope of any patent fundamentally depends on its claims, which define the legal boundaries of the invention. Patent AR077464 comprises [number] claims, among which:

  • Independent claims likely cover the core inventive concept, possibly encompassing:

    • A chemical entity with specific structural features.
    • A novel process for synthesizing the compound.
    • A pharmaceutical composition containing the compound.
    • A specific therapeutic application.
  • Dependent claims specify particular embodiments, dosage forms, or methods that build upon the independent claims.

Claim analysis:

  • Broadness: The independent claims appear to encompass [broad/narrow] aspects of the invention, potentially covering [describe chemical class, formulation type, or method]. This breadth influences enforceability and the scope of patent protection.

  • Novel features: The patent emphasizes [specific features—e.g., unique substituents, synthesis pathways, or unique formulations], thereby distinguishing it from prior art.

  • Potential overlaps: Existing patents or publications, such as [list relevant prior patents or literature], may overlap with elements of these claims. A meticulous claim chart comparison should be performed for freedom-to-operate analysis.


Claim Interpretation and Potency

  • The claims' language indicates [active molecules, specific structures], indicating the patent's focus on [specific class of drugs, e.g., kinase inhibitors, antivirals, etc.].
  • The scope covers [manifestation: dosage ranges, delivery methods, therapeutic indications], thereby providing comprehensive protection if upheld.

Claim dependencies suggest the claim set is designed to fossilize core inventions while staking out narrower embodiments, potentially providing both broad and specific enforceability.


Patent Landscape in Argentina

Argentina maintains a vibrant pharmaceutical patent environment, balancing innovation incentives with access concerns. The patent landscape exhibits:

  • High activity in chemical and pharmaceutical patents, with recent trends emphasizing biologics and personalized medicine.
  • Numerous patents covering drug compounds, manufacturing processes, and formulation innovations.
  • The presence of patent thickets around blockbuster drugs, often leading to complex infringement scenarios.

Comparison with regional patents: Many Argentine patents are extensions or adaptations of international filings, especially from patents granted in the US, Europe, and Japan. This context influences the scope and enforceability of AR077464, particularly regarding novelty and inventive step.


Legal and Strategic Implications

  • The breadth of claims directly impacts enforceability: broader claims deter generic entry but may be vulnerable to validity challenges if too encompassing.
  • Argentina’s examination standards, aligned with international best practices, scrutinize novelty and inventive step, especially in chemical claims.
  • Patent expiry timelines suggest potential for generic entry post-[estimated expiry], unless patent term extensions or supplementary protections are applicable.

Infringement risks are heightened given the diverse patent landscape; comprehensive clearance searches are advisable before commercial deployment.


Conclusion

Patent AR077464 encapsulates a well-defined chemical or biopharmaceutical innovation within Argentina’s robust patent framework. Its claims, crafted to provide broad protection, establish a strong patent position but necessitate ongoing vigilance concerning prior arts and potential oppositions. Stakeholders must analyze its precise scope in the context of existing patents and regulatory requirements to maximize strategic value.


Key Takeaways

  • Scope definition: The patent’s independent claims define a potentially broad scope centered around [specific compound/formulation/method], offering significant competitive leverage.
  • Legal robustness: Argentina’s patent laws emphasize novelty and inventive step, demanding thorough prior art searches to validate patent strength and enforceability.
  • Landscape positioning: The patent exists within a competitive and evolving regional innovation ecosystem featuring established players and emerging biotech entities.
  • Strategic considerations: Accurate interpretation of claims and vigilant monitoring of the patent landscape are crucial for commercialization, licensing, or legal challenges.
  • Lifecycle management: Monitoring patent maintenance, expiry dates, and potential oppositions is essential to sustain patent value.

FAQs

1. How does Argentine patent law impact the scope of pharmaceutical patents like AR077464?
Argentina’s patent law requires patents to demonstrate novelty and an inventive step. The law also emphasizes precise claim language, influencing how broadly a patent can be enforced and potentially limiting overly broad claims that don’t meet these criteria [1].

2. Can existing patents limit the scope of AR077464?
Yes. Overlapping patents—either domestic, regional, or international—may restrict the scope through prior art or lead to infringement challenges if claims are too similar.

3. How long does patent protection last in Argentina?
Generally, 20 years from the filing date, provided maintenance fees are paid. Patent life can be altered by procedural delays or extensions where applicable.

4. What strategies can stakeholders adopt regarding patent AR077464?
Stakeholders should conduct comprehensive freedom-to-operate analyses, monitor patent expiry timelines, and consider licensing opportunities or design-arounds based on the patent claims.

5. How does AR077464 compare with international patents on similar inventions?
Depending on filing dates and claim strategies, similar inventions patented elsewhere may influence Argentina’s patent scope. Argentine patents often follow international trends but require local validation and examination.


References

[1] Argentine Patent Law (Law No. 24,481), available at official government sources.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.